Adamas Pharma, LLC
11Patents
11Active
11Granted
50Portfolio score
Filing activity: Jun 17, 2014 → Jun 4, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10646456B2 | Methods of administering amantadine | Human Necessities | 34 | Active |
| US9867791B2 | Method of administering amantadine prior to a sleep period | Human Necessities | 16 | Active |
| US9867793B2 | Method of administering amantadine prior to a sleep period | Human Necessities | 15 | Active |
| US9867792B2 | Method of administering amantadine prior to a sleep period | Human Necessities | 15 | Active |
| US9877933B2 | Method of administering amantadine prior to a sleep period | Human Necessities | 15 | Active |
| US10154971B2 | Methods of administering amantadine | Human Necessities | 8 | Active |
| US11077073B2 | Methods of using amantadine compositions | Human Necessities | 2 | Active |
| US11065213B2 | Amantadine compositions and preparations thereof | Human Necessities | 2 | Active |
| US11197835B2 | Method of administering amantadine prior to a sleep period | Human Necessities | 2 | Active |
| US11903908B2 | Methods of administering amantadine | Human Necessities | 1 | Active |
| US12233033B2 | Amantadine compositions, preparations thereof, and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.